Metabolomics-Based Clinical Efficacy of Compound Shenlu Granule, a Chinese Patent Medicine, in the Supportive Management of Aplastic Anemia Patients: A Randomized Controlled Pilot Trial

Table 3

Identification results of potential biomarkers after SLG intervention.

Name	HMDB	Formula	Trend	VIP
Tryptophan	HMDB00929	C11H12N2O2	Up	1.21
Glutamate	HMDB00161	C5H9NO4	Up	1.39
Serine	HMDB00187	C3H7NO3	Up	1.15
Methionine	HMDB00696	C5H11NO2S	Up	1.42
Ornithine	HMDB0000214	C5H12N2O2	Up	2.03
PA 16:0	HMDB00674	C39H73O8P	Up	2.13
PC 22:5	HMDB08680	C48H84NO8P	Up	1.70
PC 14:0	HMDB07867	C37H69O8P	Up	1.61
Propionylcarnitine	HMDB00824	C10H20ClNO4	Up	2.85
Palmitic acid	HMDB00220	C19H38O4	Up	2.17
Acetylspermidine	HMDB01276	C9H21N3O	Down	1.06
Sphingosine	HMDB00252	C18H37NO2	Down	1.47
5-HETE	HMDB11134	C20H32O3	Down	1.08
Azelaic acid	HMDB00784	C9H16O4	Down	1.35